From the Evolut Pro to the Evolut FX self-expanding transcatheter aortic valve replacement systems: current status and future perspectives
- PMID: 36005274
- DOI: 10.1080/17434440.2022.2113386
From the Evolut Pro to the Evolut FX self-expanding transcatheter aortic valve replacement systems: current status and future perspectives
Abstract
Introduction: Since the initial experience with the CoreValve (Medtronic, Minneapolis, Minnesota), there have been continuous iterations of this valve system in order to improve procedural success and reduce periprocedural complications. The Evolut Pro, Pro+, and FX are the latest generations of this transcatheter heart valve (THV).
Areas covered: This review paper aims to analyze the main characteristics and clinical evidence about the Evolut Pro THV and summarize the main iterations of the newer generation Evolut FX valve system.
Expert opinion: The Evolut Pro system has been associated with good clinical outcomes and excellent valve hemodynamic performance including reduced rates of paravalvular leaks. Technical enhancements to improve valve positioning, orientation, and vascular access have been implemented in the newer generation Evolut FX system.
Keywords: Corevalve; Evolut FX; Evolut Pro; Evolut R; TAVR.
Similar articles
-
Early experience with the Evolut FX self-expanding valve vs. Evolut PRO+ for patients with aortic stenosis undergoing TAVR.Cardiovasc Revasc Med. 2023 Nov;56:1-6. doi: 10.1016/j.carrev.2023.06.003. Epub 2023 Jun 5. Cardiovasc Revasc Med. 2023. PMID: 37453813
-
Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry.JACC Cardiovasc Interv. 2020 Jan 27;13(2):170-179. doi: 10.1016/j.jcin.2019.08.035. JACC Cardiovasc Interv. 2020. PMID: 31973793
-
Risk of Coronary Obstruction and Feasibility of Coronary Access After Repeat Transcatheter Aortic Valve Replacement With the Self-Expanding Evolut Valve: A Computed Tomography Simulation Study.Circ Cardiovasc Interv. 2020 Dec;13(12):e009496. doi: 10.1161/CIRCINTERVENTIONS.120.009496. Epub 2020 Dec 4. Circ Cardiovasc Interv. 2020. PMID: 33272031
-
The Evolut R and Evolut PRO transcatheter aortic valve systems.Expert Rev Med Devices. 2019 Jan;16(1):3-9. doi: 10.1080/17434440.2019.1557045. Epub 2018 Dec 16. Expert Rev Med Devices. 2019. PMID: 30518281 Review.
-
Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: evidence on the benefit of a meta-analytical approach.J Cardiovasc Med (Hagerstown). 2019 Apr;20(4):226-236. doi: 10.2459/JCM.0000000000000757. J Cardiovasc Med (Hagerstown). 2019. PMID: 30829877
Cited by
-
Predictors of Conduction Disturbances Requiring New Permanent Pacemaker Implantation following Transcatheter Aortic Valve Implantation Using the Evolut Series.J Clin Med. 2023 Jul 22;12(14):4835. doi: 10.3390/jcm12144835. J Clin Med. 2023. PMID: 37510950 Free PMC article.
-
Neo-Commissural Alignment by Withdrawing and Readvancing the Delivery System during Transcatheter Aortic Valve Replacement with Self-Expanding Prosthesis.J Interv Cardiol. 2023 Dec 11;2023:1060481. doi: 10.1155/2023/1060481. eCollection 2023. J Interv Cardiol. 2023. PMID: 38116127 Free PMC article.
-
Personalised Treatment in Aortic Stenosis: A Patient-Tailored Transcatheter Aortic Valve Implantation Approach.J Cardiovasc Dev Dis. 2022 Nov 21;9(11):407. doi: 10.3390/jcdd9110407. J Cardiovasc Dev Dis. 2022. PMID: 36421942 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
